Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country crawled date : 2022 - 01 - 06 save search
Rafael Pharmaceuticals Announces Successful Completion of Dose Escalation with No Dose-Limiting Toxicity (DLT) in First Cohort of APOLLO 613 Phase
Published: 2022-01-06 (Crawled : 21:00) - biospace.com/
RFL 4 | $1.705 -2.01% 7.9K
|
Finance
|
| O: 5.98%
H: 0.4%
C: -2.62%
als ces 613
Cyclacel Pharmaceuticals Reviews 2021 Achievements And Announces Key Business Objectives for 2022
Published: 2022-01-06 (Crawled : 21:00) - biospace.com/
CYCC | $1.72 -1.71% 14K
|
Health Technology
|
| O: -1.33%
H: 1.84%
C: -2.33%
als ces cel
Anavex Life Sciences Promotes Walter E Kaufmann, M.D. to Chief Scientific Officer and Appoints Edward R Hammond, M.D., M.P.H., Ph.D., as Chief Medical Officer
Published: 2022-01-06 (Crawled : 19:00) - biospace.com/
AVXL | $3.755 2.04% 900K
|
Health Technology
|
| O: 1.17%
H: 2.89%
C: 0.77%
ces life science anavex
Iveric Bio Announces the Addition of Global Pharmaceutical Veteran, Christine Ann Miller, to its Board of Directors
Published: 2022-01-06 (Crawled : 19:00) - biospace.com/
ISEE | $39.95 0.38% 0.38% 0
|
Health Technology
|
| O: 0.21%
H: 1.74%
C: -2.09%
ces
Immunocore to present at the 40th Annual J.P. Morgan Healthcare Conference
Published: 2022-01-06 (Crawled : 14:00) - biospace.com/
IMCR | $57.565 3.13% 220K
|
Manufacturing
|
| O: 0.82%
H: 2.94%
C: -4.97%
health thc conference j.p. morgan healthcare conference
Rallybio Highlights Portfolio Advances and Outlines Expected Upcoming Milestones for 2022
Published: 2022-01-06 (Crawled : 14:00) - biospace.com/
RLYB | News | $1.84 3.96% 160K
|
|
| O: 0.83%
H: 6.82%
C: 5.88%
milestone
IN8bio Announces Clinical Updates from the Phase 1 Clinical Trial of its Genetically Modified Gamma-Delta T Cell Therapy in Newly Diagnosed Glioblastoma Multiforme
Published: 2022-01-06 (Crawled : 14:00) - biospace.com/
INAB | $1.0126 1.27% 260K
|
|
| O: 4.66%
H: 2.34%
C: 2.34%
genetic trial cel phase 1 therapy t-cell glioblastoma
BD Publishes 2021 Cybersecurity Annual Report
Published: 2022-01-06 (Crawled : 12:00) - biospace.com/
BDX | $235.11 0.53% 370K
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
cybersecurity security
Portage Biotech Announces Participation in January 2022 Investor Conferences
Published: 2022-01-05 (Crawled : 10:00) - biospace.com/
PRTG | $0.241 -18.91% 160K
|
Mining, Quarrying, and Oil and ...
|
| O: -0.96%
H: 3.54%
C: 2.92%
ces conference biotech iot
Gainers vs Losers
| 86% | 14% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.74 119.2% 52M
|
Finance
CZOO | $9.07 81.76% 22M
|
EDBL | News | $6.56 74.47% 1.8M
|
MTC | $2.21 41.67% 5.6M
|
Technology Services
OPRT | News | $3.12 38.67% 11M
|
Finance
PALI | $6.59 33.67% 23M
|
Manufacturing
VNRX | $0.7989 33.15% 3.2M
|
Health Technology
BTCM | $3.51 30.0% 730K
|
Arts, Entertainment, and Recrea...
MLEC | $1.81 29.29% 2.8M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.